{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:02:06Z","timestamp":1771264926745,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:00:00Z","timestamp":1699660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:00:00Z","timestamp":1699660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1245\/s10434-023-14531-y","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T23:01:47Z","timestamp":1699743707000},"page":"792-803","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neoadjuvant Therapy for Duodenal and Ampullary Adenocarcinoma: A Systematic Review"],"prefix":"10.1245","volume":"31","author":[{"given":"Chunmeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M.","family":"Lizalek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collin","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle M.","family":"Westmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey A.","family":"Klute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley N.","family":"Reames","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,11]]},"reference":[{"key":"14531_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0039-6109(05)70142-0","volume":"81","author":"JM Sarmiento","year":"2001","unstructured":"Sarmiento JM, Nagomey DM, Sarr MG, Farnell MB. Periampullary cancers: are there differences? Surg Clin North Am. 2001;81:543\u201355.","journal-title":"Surg Clin North Am."},{"key":"14531_CR2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S0959-8049(05)80349-1","volume":"29A","author":"KE Bakkevold","year":"1993","unstructured":"Bakkevold KE, Arnesjo B, Dahl O, Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater: results of a controlled, prospective, randomised multicentre study. Eur J Cancer. 1993;29A:698\u2013703.","journal-title":"Eur J Cancer."},{"key":"14531_CR3","doi-asserted-by":"crossref","unstructured":"Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg. 1999;230:776\u201382; discussion 782\u20134.","DOI":"10.1097\/00000658-199912000-00006"},{"key":"14531_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jama.2012.7352","volume":"308","author":"JP Neoptolemos","year":"2012","unstructured":"Neoptolemos JP, Moore MJ, Cox TF, et al. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA. 2012;308:147\u201356.","journal-title":"JAMA."},{"key":"14531_CR5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ejso.2018.02.008","volume":"44","author":"Z Jin","year":"2018","unstructured":"Jin Z, Hartgers ML, Sanhueza CT, et al. Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience. Eur J Surg Oncol. 2018;44:677\u201383.","journal-title":"Eur J Surg Oncol."},{"issue":"4","key":"14531_CR6","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.surg.2021.03.046","volume":"170","author":"NP Vo","year":"2021","unstructured":"Vo NP, Nguyen HS, Loh EW, Tam KW. Efficacy and safety of adjuvant therapy after curative surgery for ampullary carcinoma: a systematic review and meta-analysis. Surgery. 2021;170(4):1205\u201314.","journal-title":"Surgery."},{"issue":"9","key":"14531_CR7","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1245\/s10434-018-6567-6","volume":"25","author":"LL Meijer","year":"2018","unstructured":"Meijer LL, Alberga AJ, de Bakker JK, et al. Outcomes and treatment options for duodenal adenocarcinoma: a systematic review and meta-analysis. Ann Surg Oncol. 2018;25(9):2681\u201392.","journal-title":"Ann. Surg. Oncol."},{"key":"14531_CR8","doi-asserted-by":"crossref","unstructured":"Turpin A, El Amrani M, Zaanan A. Localized small bowel adenocarcinoma management: evidence summary. Cancers (Basel). Jun 11 2022;14(12).","DOI":"10.3390\/cancers14122892"},{"key":"14531_CR9","unstructured":"National Comprehensive Cancer Network. Small Bowel. 2022; https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/small_bowel.pdf. Accessed 13 Dec 2022."},{"key":"14531_CR10","unstructured":"National Comprehensive Cancer Network. Ampullary Adenocarcinoma. 2022; https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ampullary.pdf. Accessed 13 Dec 2022."},{"key":"14531_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fonc.2020.00245","volume":"10","author":"A Oba","year":"2020","unstructured":"Oba A, Ho F, Bao QR, Al-Musawi MH, Schulick RD, Del Chiaro M. Neoadjuvant treatment in pancreatic cancer. Front Oncol. 2020;10:245.","journal-title":"Front Oncol."},{"key":"14531_CR12","unstructured":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). http:\/\/www.prisma-statement.org\/?AspxAutoDetectCookieSupport=1. Accessed 3 May 2023."},{"key":"14531_CR13","doi-asserted-by":"crossref","unstructured":"Sterne JA, Hernan MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","DOI":"10.1136\/bmj.i4919"},{"issue":"3","key":"14531_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.pan.2020.01.009","volume":"20","author":"L Bolm","year":"2020","unstructured":"Bolm L, Ohrner K, Nappo G, et al. Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy: a multicenter cohort study. Pancreatology. 2020;20(3):433\u201341.","journal-title":"Pancreatology."},{"issue":"3","key":"14531_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/jso.25336","volume":"119","author":"CA Hester","year":"2019","unstructured":"Hester CA, Dogeas E, Augustine MM, et al. Incidence and comparative outcomes of periampullary cancer: a population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012. J Surg Oncol. 2019;119(3):303\u201317.","journal-title":"J. Surg. Oncol."},{"key":"14531_CR16","doi-asserted-by":"crossref","unstructured":"de Jong EJM, van der Geest LG, Besselink MG, et al. Treatment and overall survival of four types of non-metastatic periampullary cancer: nationwide population-based cohort study. HPB : Off. J. Int. Hepato Pancreato Biliary Assoc. 2022.","DOI":"10.1016\/j.hpb.2022.01.009"},{"key":"14531_CR17","doi-asserted-by":"crossref","unstructured":"Manoukian G, Lal A, Wen S, et al. Neoadjuvant therapy for adenocarcinomas of the duodenum and ampulla of Vater. J. Clin. Oncol. 2011;29(4).","DOI":"10.1200\/jco.2011.29.4_suppl.279"},{"issue":"6","key":"14531_CR18","doi-asserted-by":"publisher","first-page":"e000960","DOI":"10.1136\/esmoopen-2020-000960","volume":"5","author":"A Colina","year":"2020","unstructured":"Colina A, Hwang H, Wang H, et al. Natural history and prognostic factors for localised small bowel adenocarcinoma. ESMO Open. 2020;5(6):e000960-000960.","journal-title":"ESMO Open."},{"key":"14531_CR19","first-page":"S240","volume":"31","author":"M Abo-Ryia","year":"2017","unstructured":"Abo-Ryia M, Abd-Allah H, El-Khadrawy O, Moussa GI, El-Shora A, Saber SA. Primary duodenal malignancies: 2 Year experience at a tertiary hospital. Surg Endosc Other Intervent Tech. 2017;31:S240.","journal-title":"Surg Endosc Other Intervent Tech."},{"issue":"5","key":"14531_CR20","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.ijrobp.2007.05.006","volume":"69","author":"CR Kelsey","year":"2007","unstructured":"Kelsey CR, Nelson JW, Willett CG, et al. Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2007;69(5):1436\u201341.","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"14531_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s11605-011-1667-7","volume":"16","author":"EO Onkendi","year":"2012","unstructured":"Onkendi EO, Boostrom SY, Sarr MG, et al. Neoadjuvant treatment of duodenal adenocarcinoma: a rescue strategy. J Gastrointest Surg. 2012;16(2):320\u20134.","journal-title":"J. Gastrointest. Surg."},{"key":"14531_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijsu.2017.04.051","volume":"42","author":"S Bourgouin","year":"2017","unstructured":"Bourgouin S, Ewald J, Mancini J, Moutardier V, Delpero JR, Le Treut YP. Disease-free survival following resection in non-ductal periampullary cancers: a retrospective multicenter analysis. Int J Surg. 2017;42:103\u20139.","journal-title":"Int. J. Surg."},{"issue":"13","key":"14531_CR23","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1245\/s10434-017-6098-6","volume":"24","author":"S Yamashita","year":"2017","unstructured":"Yamashita S, Overman MJ, Wang H, et al. Pathologic response to preoperative therapy as a novel prognosticator for ampullary and duodenal adenocarcinoma. Ann Surg Oncol. 2017;24(13):3954\u201363.","journal-title":"Ann. Surg. Oncol."},{"key":"14531_CR24","doi-asserted-by":"crossref","unstructured":"Adam MA, Glencer A, AlMasri S, et al. Neoadjuvant therapy versus upfront resection for nonpancreatic periampullary adenocarcinoma. Ann. Surg. Oncol. 2022.","DOI":"10.1245\/s10434-022-12257-x"},{"key":"14531_CR25","doi-asserted-by":"crossref","unstructured":"Cecchini S, Correa-Gallego C, Desphande V, et al. Superior prognostic importance of perineural invasion vs. lymph node involvement after curative resection of duodenal adenocarcinoma. J. Gastrointest. Surg. 2012;16(1):113\u2013120; discussion 120.","DOI":"10.1007\/s11605-011-1704-6"},{"key":"14531_CR26","doi-asserted-by":"crossref","unstructured":"Lee SY, Lee JH, Hwang DW, Kim SC, Park KM, Lee YJ. Long-term outcomes in patients with duodenal adenocarcinoma. ANZ J. Surg. 2014;84(12):970\u2013975.","DOI":"10.1111\/ans.12112"},{"issue":"2","key":"14531_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.suronc.2015.04.004","volume":"24","author":"T Buchbjerg","year":"2015","unstructured":"Buchbjerg T, Fristrup C, Mortensen MB. The incidence and prognosis of true duodenal carcinomas. Surg Oncol. 2015;24(2):110\u20136.","journal-title":"Surg. Oncol."},{"key":"14531_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jss.2020.03.017","volume":"252","author":"TC Lee","year":"2020","unstructured":"Lee TC, Wima K, Morris MC, et al. Small bowel adenocarcinomas: impact of location on survival. J Surg Res. 2020;252:116\u201324.","journal-title":"J. Surg. Res."},{"key":"14531_CR29","doi-asserted-by":"crossref","unstructured":"Linden K, Melillo A, Gaughan J, et al. The role of neoadjuvant versus adjuvant therapy for duodenal adenocarcinoma: a national cancer database propensity score matched analysis. Am. Surg. 2021;87(7):1066\u20131073.","DOI":"10.1177\/0003134820954821"},{"issue":"5","key":"14531_CR30","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1245\/s10434-011-2117-1","volume":"19","author":"M Palta","year":"2012","unstructured":"Palta M, Patel P, Broadwater G, et al. Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy. Ann Surg Oncol. 2012;19(5):1535\u201340.","journal-title":"Ann. Surg. Oncol."},{"issue":"7","key":"14531_CR31","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1245\/s10434-017-5777-7","volume":"24","author":"JM Cloyd","year":"2017","unstructured":"Cloyd JM, Wang H, Overman M, et al. Influence of preoperative therapy on short- and long-term outcomes of patients with adenocarcinoma of the ampulla of Vater. Ann Surg Oncol. 2017;24(7):2031\u20139.","journal-title":"Ann. Surg. Oncol."},{"issue":"7","key":"14531_CR32","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1002\/jso.26435","volume":"123","author":"M Guo","year":"2021","unstructured":"Guo M, Beal EW, Miller ED, et al. Neoadjuvant therapy versus surgery first for ampullary carcinoma: a propensity score-matched analysis of the NCDB. J Surg Oncol. 2021;123(7):1558\u201367.","journal-title":"J. Surg. Oncol."},{"key":"14531_CR33","doi-asserted-by":"publisher","first-page":"S562","DOI":"10.1016\/j.hpb.2021.06.211","volume":"23","author":"D Patel","year":"2021","unstructured":"Patel D, Jankov A, Gravenor D, et al. Clinical, operative, and pathologic outcomes following neoadjuvant therapy versus upfront surgery for ampullary, duodenal and distal bile duct adenocarcinoma. HPB. 2021;23:S562\u20133.","journal-title":"HPB."},{"issue":"1","key":"14531_CR34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.surg.2022.03.009","volume":"172","author":"SR Kaslow","year":"2022","unstructured":"Kaslow SR, Prendergast K, Vitiello GA, et al. Systemic therapy for duodenal adenocarcinoma: an analysis of the National Cancer Database (NCDB). Surgery. 2022;172(1):358\u201364.","journal-title":"Surgery."},{"issue":"1","key":"14531_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/SLA.0000000000001182","volume":"262","author":"J Kwon","year":"2015","unstructured":"Kwon J, Kim BH, Kim K, Chie EK, Ha SW. Survival benefit of adjuvant chemoradiotherapy in patients with ampulla of Vater cancer: a systematic review and meta-analysis. Ann Surg. 2015;262(1):47\u201352.","journal-title":"Ann. Surg."},{"issue":"4","key":"14531_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s11605-017-3624-6","volume":"22","author":"I Nassour","year":"2018","unstructured":"Nassour I, Hynan LS, Christie A, et al. Association of adjuvant therapy with improved survival in ampullary cancer: a National Cohort Study. J Gastrointest Surg. 2018;22(4):695\u2013702.","journal-title":"J. Gastrointest. Surg."},{"key":"14531_CR37","doi-asserted-by":"crossref","unstructured":"Kim YI, Park JW, Kim BH, et al. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma. Radiat. Oncol. Dec 21 2013;8:292.","DOI":"10.1186\/1748-717X-8-292"},{"issue":"2","key":"14531_CR38","first-page":"737","volume":"36","author":"R Autorino","year":"2016","unstructured":"Autorino R, Mattiucci GC, Ardito F, et al. Radiochemotherapy with gemcitabine in unresectable extrahepatic cholangiocarcinoma: long-term results of a phase II study. Anticancer Res. 2016;36(2):737\u201340.","journal-title":"Anticancer Res."},{"issue":"11","key":"14531_CR39","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1200\/JCO.21.02233","volume":"40","author":"E Versteijne","year":"2022","unstructured":"Versteijne E, van Dam JL, Suker M, et al. Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial. J Clin Oncol. 2022;40(11):1220\u201330.","journal-title":"J. Clin. Oncol."},{"issue":"33","key":"14531_CR40","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.1200\/JCO.2008.17.5299","volume":"26","author":"DG Blazer 3rd","year":"2008","unstructured":"Blazer DG 3rd, Kishi Y, Maru DM, et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol. 2008;26(33):5344\u201351.","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"14531_CR41","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1002\/cncr.26651","volume":"118","author":"D Chatterjee","year":"2012","unstructured":"Chatterjee D, Katz MH, Rashid A, et al. Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome. Cancer. 2012;118(12):3182\u201390.","journal-title":"Cancer."},{"key":"14531_CR42","doi-asserted-by":"crossref","unstructured":"Hank T, Strobel O. Conversion surgery for advanced pancreatic cancer. J Clin Med. 2019;8(11).","DOI":"10.3390\/jcm8111945"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14531-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-14531-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14531-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T15:24:25Z","timestamp":1704209065000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-14531-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,11]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["14531"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-14531-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,11]]},"assertion":[{"value":"19 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}